Cationic nanoemulsions as potential carriers for intracellular delivery  by Khachane, P.V. et al.
Saudi Pharmaceutical Journal (2015) 23, 188–194King Saud University
Saudi Pharmaceutical Journal
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLECationic nanoemulsions as potential carriers
for intracellular delivery* Corresponding author. Tel.: +91 9820532898.
E-mail address: mangal.nagarsenker@gmail.com (M.S. Nagarsenker).
Peer review under responsibility of King Saud University.
Production and hosting by Elsevier
http://dx.doi.org/10.1016/j.jsps.2014.07.007
1319-0164 ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.P.V. Khachane a, A.S. Jain a, V.V. Dhawan a, G.V. Joshi b, A.A. Date a,c,
R. Mulherkar b, M.S. Nagarsenker a,*a Department of Pharmaceutics, Bombay College of Pharmacy, Kalina, Santacruz (East), Mumbai 400098, India
b Tata Memorial Center, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Kharghar, Navi Mumbai
410210, Maharashtra, India
c School of Pharmacy and Health Professions, Creighton University, Omaha, NE 68178, USAReceived 28 April 2014; accepted 10 July 2014
Available online 18 July 2014KEYWORDS
Nanoemulsion;
Cationic;
Didodecyldimethylammoni-
um bromide;
Intracellular delivery;
Cytosolic deliveryAbstract Successful cytosolic delivery enables opportunities for improved treatment of various
genetic disorders, infectious diseases and cancer. Cationic nanoemulsions were designed using alter-
native excipients and evaluated for particle size, charge, effect of sterilization on its stability, DNA
condensation potential and cellular uptake efﬁciency. Various concentrations of non-ionic and ionic
stabilizers were evaluated to design formula for colloidally stable cationic nanoemulsion. The nano-
emulsion comprised of 5% Capmul MCM, 0.5% didodecyldimethylammonium bromide (DDAB),
1% phospholipid, 1% Poloxamer 188 and 2.25% glycerol and possessed particle size of
81.6 ± 3.56 nm and 137.1 ± 1.57 nm before and after steam sterilization, respectively. DNA con-
densation studies were carried out at various nanoemulsion: DNA ratios ranging from 1:1 to 10:1.
Cell uptake studies were conducted on human embryonic kidney (HEK) cell lines which are widely
reported for transfection studies. The nanoemulsions showed excellent cellular uptake as evaluated
by ﬂuorescence microscopy and ﬂow cytometry. Overall, a colloidally stable cationic nanoemulsion
with good DNA condensation ability was successfully fabricated for efﬁcient cytosolic delivery and
potential for in vivo effectiveness.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
A myriad of drug delivery systems are being engineered today
with the aim to achieve cytosolic delivery which enables the
actives to exert its therapeutic action within the cytoplasm,
other intracellular organelles or the nucleus. Intracellular
delivery systems are the mainstay approach for therapy of dis-
eases associated with defects arising in subcellular structures/
biochemical pathways. Novel nanocarrier systems are being
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of anti-cancer drugs as well as proapoptotic drugs and siRNA
(Torchilin, 2006; Chou et al., 2011). However, design of deliv-
ery systems for effective cytosolic delivery is challenging. The
main barrier to intracellular delivery is the lipophilic plasma
membrane which prevents the entry of compounds inside the
cell. It is well known that the cell has a negatively charged sur-
face due to the presence of sulfated proteoglycans, namely hep-
arin, heparan sulfate, dermatan sulfate, chondroitin sulfate,
and keratan sulfate. Reports have proven that these proteogly-
cans act as plasma membrane carriers (Belting, 2003) and
mediate cellular internalization of cationic delivery systems
(Mounkes et al., 1998; Mislick and Baldeschwieler, 1996).
Recently, cationic liposomes have demonstrated selectivity
for tumor vascular endothelial cells, since the tumor vessels
have an over abundance of negatively charged molecules
(Campbell et al., 2002). Besides, the drug carrier must also
escape the processes that affect the disposal of macromole-
cules, which include interaction with blood components, vas-
cular endothelial cells and uptake by the reticuloendothelial
system. Degradation of therapeutic DNA and RNA by serum
nucleases is another signiﬁcant threat for functional delivery to
the target cell (Quong and Neufeld, 1998). Thus, an ideal intra-
cellular carrier system should be able to protect and transport
the therapeutic materials to target cells without causing any
toxicity and immune responses (Smith et al., 1997). Further,
to be therapeutically useful, the delivery system should possess
small size to allow internalization into cells and when endocy-
tosed must be able to escape endosome-lysosome processing
(Mansouri et al., 2004; Jayakumar et al., 2010) .
Various systems have been designed to overcome these bar-
riers for effective intracellular delivery of drugs and genes.
These include polymeric nanoparticles, dendrimers, liposomes,
lipopolyplexes, to name a few (Shah and Amiji, 2006; Xiong
et al., 2005). Most of these systems are stable at ambient stor-
age conditions, can be produced in large quantities and pro-
duce minimum immune response in host. Besides, they can
be target speciﬁc and have advantages of high drug loading
as well as good DNA condensation capacity. Further, efﬁcient
cellular internalization is facilitated as a result of electrostatic
interaction between the cationic delivery system and the nega-
tively charged cell membrane.
It is worth noticing, that various researchers have evaluated
cationic nanoemulsions as an alternative for drug/gene deliv-
ery and it has demonstrated signiﬁcant potential to do so (de
Arau´jo et al., 2007; Liu and Yu, 2010). Cationic emulsions
designed to date use excipients like DOTAP and DOTMA.1
It is thought worthwhile to formulate cationic nanoemulsions
with alternative excipients which display good condensation,
efﬁcient cytosolic delivery and lower cytotoxicity. It is
reported, that the cationic surfactant, when used in conjunc-
tion with the non ionic surfactant demonstrates better colloidal
stability. It can be thus hypothesized, that a cationic nano-
emulsion can be formulated by optimizing the ratio of the
non ionic and the cationic surfactant rendering the fabrication
process economic. The objective of the present investigation is1 Abbreviations: DDAB, didodecyldimethyl ammonium bromide;
CTAB, cetyltrimethylammonium bromide; DOTAP, N-[1-(2,3-diol-
eoyloxy)propyl]-N,N,N-trimethylammonium methyl-sulfate; DOT-
MA, N-[1-(2, 3-dioleyloxy)propyl]-N,N,N-trimethylammonium
chloride; PCS, photon correlation spectroscopy.to formulate a cationic nanoemulsion with regular excipients
for effective intracellular delivery.
2. Materials and methods
Capmul MCM was a kind gift from Abitec Corporation, USA.
Miglyol 812 and Miglyol 840 were obtained from Sasol, Ger-
many. Capryol 90 and Labrafac FCC were kind gifts from
Gattefosse Pvt. Ltd., Mumbai, India. Phospholipids were
obtained as kind gift samples from Lipoid, Germany. Tween
20, Tween 80 and stearylamine were obtained from S.D. Fine
Chem. Ltd., Mumbai, India. Solutol HS 15 and Poloxamer
188 were obtained from BASF, Mumbai, India. MYS 40 was
obtained from Nikko Chemicals Co. Ltd., Tokyo, Japan. Did-
odecyldimethylammonium bromide (DDAB) and Cetyltri-
methylammonium bromide (CTAB) were purchased from
Fluka Chemicals (New Jersey, USA). Ethanol was purchased
from S.D.Fine Chem. Ltd., Mumbai, India and Glycerol from
Qualigens, Mumbai, India.
2.1. Formulation and optimization of cationic nanoemulsions
Cationic nanoemulsion was fabricated by the probe sonication
method (Fig. 1). The components of the nanoemulsions
included an oil, non-ionic and/or ionic surfactant, osmotic
agent, phospholipids and 0.2 lm double ﬁltered distilled water.
Brieﬂy, the aqueous phase and the oil phase were separately
heated on a water bath at 70 C. The aqueous phase was
then added to the oily phase under vortex (REMI CM101)
to spontaneously produce coarse emulsions. The coarse
emulsion was then transferred to a vial preheated at 70 C.
The coarse emulsion was probe sonicated for 5 minutes at an
output of 35 W to yield the ﬁnal nanoemulsion formulation.
Nanoemulsions were prepared with varying compositions
and concentrations of surfactants and oils. The prepared
nanoemulsions were evaluated for colloidal stability after
being autoclaved.
2.2. Characterization of cationic nanoemulsions
2.2.1. Particle size analysis and zeta potential measurements
Particle size analysis was carried out on a photon correlation
spectroscopy (PCS) equipment (Beckman Coulter, N5 submi-
cron particle size analyzer) after appropriate dilution with
0.2 lm double ﬁltered distilled water. Zeta Potential was mea-
sured using the Malvern Zetasizer, nanoseries.
2.2.2. Freeze drying of cationic nanoemulsions
The ﬁnal optimized nanoemulsion was freeze dried with con-
denser temperature of 60 C and 200 torr pressure. The
freeze dried product was then reconstituted with 0.2 lm double
ﬁltered distilled water to evaluate the effect of lyophilization
on particle size and polydispersity of nanoemulsion as shown
by PCS evaluation.
2.2.3. DNA condensation study (Hung et al., 2005)
The nanoemulsion was appropriately diluted to yield the ﬁnal
DDAB concentration of 1 lg/ll in the ﬁnal dilution. The con-
centration of the DNA solution was 1 lg/ll in tris-EDTA buf-
fer (20 mM Tris-Cl and 1 mM EDTA pH 7.5). This DNA
Figure 1 Schematic of cationic nanoemulsion formulation and condensation with DNA.
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cationic nanoemulsion to a ﬁxed total reaction volume. Four
ratios of carrier: DNA viz. 1:1; 3:1; 5:1; 10:1 were evaluated
for complexation. The solutions were incubated for 1 h and
10 lL aliquots of the complexes were mixed with 10 lL of
the loading buffer (0.25% bromophenol blue and 30% glyc-
erol) and samples were loaded onto 0.8% w/v agarose gel.
The samples were loaded into ﬁve lanes as follows: Lane 1:Table 1 Formula of cationic nanoemulsion.
Ingredients Proposed use %w
Capmul MCM Oil phase 5
Poloxamer 188 Impart better stabilization 1
DDAB Impart positive charge 0.5
PL 90 H Impart Thermal stability 0.5
Glycerol Impart isoosmolarity 2.25
Water Vehicle q.s.
Table 2 Compositions of batches for optimization of prototype fo
Formulation Capmul MCM
Prototype formula (S1) 5
S2 5
S3 5
S4 5
S5 5
S6 2.5
S7 2.5
S8 2.5
Final optimized Formula (S9) 5Naked DNA; Lane 2: DNA: Carrier (1:1); Lane 3: DNA: Car-
rier (1:3); Lane 4: DNA: Carrier (1:5); Lane 5: DNA: Carrier
(1:10). Electrophoresis was carried out with a current of 70 V
for about 2 h in tris-borate-EDTA running buffer (100 mM
Tris-Cl, 100 mM boric acid and 2 mM EDTA pH 7.5). After
1 h of staining with ethidium bromide, gel photographs were
taken under UV light. Naked DNA was also allowed to run
on the gel as control./v (prototype formula) %w/v (optimized ﬁnal formula)
5
1
0.5
1
2.25
10 gms q.s. 10 gms
rmula.
Poloxamer 188 DDAB PL 90H
1 0.5 0.5
2 0.5 0.5
3 0.5 0.5
4 0.5 0.5
5 0.5 0.5
1 0.5 1
2 0.5 1
1 1 1
1 0.5 1
Table 3 Particle size analysis of batches S1-S9.
Formulation Before sterilization After autoclaving Other observations
M.P.S. P.I. M.P.S. P.I.
Prototype formula (S1) 73.2 ± 9.21 0.709 ± 0.053 111.7 ± 3.28 0.524 ± 0.126 Not stable for long after autoclaving
S2 108.3 ± 2.07 0.963 ± 0.046 NS NS Oil globules seen under microscope
S3 101.0 ± 1.67 0.615 ± 0.002 NS NS Same as S2
S4 95.3 ± 1.15 0.951 ± 0.004 NS NS Same as S2
S5 65.5 ± 1.54 0.839 ± 0.048 NS NS Same as S2
S6 70.2 ± 1.94 NS NS NS Same as S2
S7 87.0 ± 3.83 NS NS NS Same as S2
S8 72.3 ± 5.69 NS NS NS Same as S2
S9 81.6 ± 3.56 0.767 ± 0.18 137.1 ± 1.57 0.210 ± 0.042 M.P.S. 6 h after autoclaving: 143.1 ± 5.11;
P.I.: 0.271 ± 0.166
M.P.S.: Mean particle size; P.I.: Polydispersity index; NS: Not satisfactory.
Cationic nanoemulsions as potential carriers for intracellular delivery 1912.2.4. Fluorescence microscopy and ﬂow cytometry
HEK (Human embryonic kidney) cells were seeded (2 · 105/
well) in 35 mm plate with 2 mL of growth medium, and incu-
bated at 37 C, in a CO2 incubator for 24 h prior to addition of
formulations. Cells were treated with cationic nanoemulsions
containing nile red dye (100 lg/mL) or vehicle alone at
37 C. After 48 h, the plates were observed under a ﬂuores-
cence microscope. Representative ﬁelds were visualized and
photographed with an Axiovert 200 M (Inverted Microscope)
Carl Zeiss, Germany. Exposure times were 300–500 millisec-
onds. Treated cells and their corresponding untreated control
cells were then harvested for ﬂow cytoﬂuorometry. Cells were
washed with 1 · PBS and spun at 2000 rpm for 10 min at room
temperature. Cells were suspended in 1 · PBS (500 lL). Cells
were acquired on a Flow Cytometer (FACS Calibur BD) to
quantify the red ﬂuorescence (FL2) and the results were ana-
lyzed using the CellQuestPro software. The study was carried
out at two concentrations i.e., 0.3 lL and 0.6 lL of
nanoemulsion.Figure 2 DNA condensation results. Lane 1 shows naked DNA
whereas absence of bands on the gel in Lane 2, 3 and 4 indicates
complete condensation between the DNA and the delivery system.3. Results and discussion
Various oils were evaluated to fabricate colloidally stable
nanoemulsions that included Miglyol 812 and 840, Labrafac
FCC, Capryol 90 and Capmul MCM at concentrations of
2.5% w/v and 5% w/v. It was observed that all oils evaluated
except Capmul MCM, at concentrations of 2.5% w/v and 5%
w/v in combination with various stabilizers at varying concen-
trations could yield nanoemulsion with size ranging from 120
to 240 nm and poor colloidal stability (data not shown). How-
ever, Capmul MCM at both concentrations yielded cationic
nanoemulsion with size less than 85 nm. Formulae were pre-
pared using only non-ionic surfactants and combination of
both, ionic and non-ionic surfactants, to enable better under-
standing about stabilizing potential of ionic surfactants. Non
ionic stabilizers evaluated include Polysorbate 80, Solutol HS
15, Mys 40 and Poloxamer 188, whereas CTAB and DDAB
were ionic surfactants employed. 2.25% w/v glycerol was a
part of all formulations to impart iso-osmolarity to
formulations.
It was observed that, nanoemulsions containing only non-
ionic stabilizers did not possess adequate colloidal stability.
Non-ionic surfactants were thought to be inefﬁcient alone tocontrol Ostwald ripening phenomenon at concentrations
employed, resulting in rapid aggregation of oil globules and
destabilization (Jain et al., 2011). In combination with ionic
surfactants, however, scenario changed and nanoemulsions
with better colloidal stability were formed. This depicts better
stabilizing potential of ionic surfactants, probable mechanism
being the positive charge imparted on globule surface causing
them to repel each other and minimizing aggregation. Nano-
emulsions with and without phospholipids were prepared
and autoclaved. Those without phospholipids could not main-
tain their colloidal stability on being autoclaved, whereas ones
containing phospholipids showed slight increase in particle size
with retention of colloidal stability. It was evident that phos-
pholipids conferred sufﬁcient thermal stability to cationic
nanoemulsions to be conveniently autoclaved without drastic
increase in particle size and polydispersity. On autoclaving, it
was observed that cationic nanoemulsions containing DDAB
demonstrated less increase in particle size as compared to
CTAB, which on combination with any surfactant could not
control enormous growth in globule size, hence DDAB incor-
porated nanoemulsion was utilized for further studies.
Nanoemulsion comprising of Capmul MCM, DDAB,
phospholipid and Poloxamer 188 was ﬁnally selected for fur-
ther studies as it demonstrated adequate colloidal stability
before and after autoclave sterilization. The formula of
prototype cationic nanoemulsion is mentioned in Table 1.
Further optimization studies were conducted, by varying
Figure 4 Flow cytometry histograms of untreated control and nanoemulsion treated cells.
Figure 3 Fluorescence images of HEK cells (A) and (B) represent merged and ﬂuorescence images of untreated control whereas (C) and
(D) represent the merged and ﬂuorescence images of nanoemulsion treated cells, respectively.
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evaluate their effect on the stability of nanoemulsion. Concen-
tration of Poloxamer was varied from 1% w/v to 5% w/v. It
was observed that as concentration of Poloxamer increased,
globule size decreased. However, the formulation did not show
adequate duration of stability with coagulation of oil globules
observed within few minutes. The probable reason could be
attributed to an increase in concentration of Poloxamer 188
which reduced the amount of DDAB at globule surface thus
reducing colloidal stability. Thus, concentration of Poloxamer
188 was ﬁxed to 1% w/v in the ﬁnal formula. Surprisingly, it
was observed that inclusion of Capmul MCM at concentration
of 5% w/v could confer better colloidal stability as compared
to 2.5% w/v. Increase in phospholipid concentration from
0.5% w/v to 1% w/v was found to improve stability after auto-
claving without signiﬁcant effect on mean particle size. The
ﬁnal optimized formula employed for DNA condensation
studies and intracellular delivery possessing adequate stability
before and after autoclaving is mentioned in Table 1. Tables 2
and 3 depict optimization of prototype formula with effect of
autoclaving on different batches. Zeta potential measurement
demonstrated that optimized cationic nanoemulsion possessed
surface charge of +40 mV explaining its good colloidal stabil-
ity due to repulsion between oil globules and reduced aggrega-
tion. Autoclaving resulted in slight increase in particle size.
However, even after sterilization, optimized nanoemulsion
possessed adequate colloidal stability as mentioned in Table 3.
Cationic nanoemulsions were freeze dried to improve their sta-
bility upon storage, thus aiding their potential for commercial-
ization. Trehalose was employed as cryoprotectant at
concentration of 10% based on earlier reports about its poten-
tial of being effective cryoprotectant in most cases. The particle
size of the nanoemulsion after freeze drying and reconstitution
was 120 nm with a polydispersity of 0.5.
Gel electrophoresis was performed to evaluate the complex-
ation between the cationic carrier and the DNA. As observed
in Fig. 2, effective complexation was observed at carrier: DNA
ratios of 1:1; 3:1; 5:1; 10:1. It was interesting to note that effec-
tive complexation was achieved at a ratio as low as 1:1. At
higher carrier concentrations, neither free nor retarded DNA
bands were observed in the sample. The condensation of the
DNA by the cationic nanoemulsion prevented ethidium bro-
mide from intercalating with the base pairs of the DNA
thereby accounting for disappearance of bands. Cell uptake
studies were performed using ﬂuorescence microscopy and
ﬂuorescence was quantiﬁed using ﬂow cytometry. The phase
contrast and ﬂuorescence micrographs of control and treated
HEK cells are shown in Fig. 3. When cell uptake was studied
at 1:1 ratio of DNA: carrier, cell cytotoxicity was observed.
Therefore cell uptake assay was performed using 1:0.5 ratio
of DNA: cationic agent. It is seen from the ﬁgures, that most
of the cells are ﬂuorescent with negligible background ﬂuores-
cence. Nile red is a hydrophobic dye and has been reported to
determine cellular lipid content since it is strongly ﬂuorescent
in the presence of hydrophobic environment. The dye is asso-
ciated with the oily part of nanoemulsions and its presence
inside the cells can therefore be anticipated due to internaliza-
tion of the nanoemulsion droplets inside the cells thereby ren-
dering the cells ﬂuorescent. Cells were examined for red
ﬂuorescence by ﬂow cytoﬂuorometry. The histograms indicate
that cells loaded with the nanoemulsions have increased
ﬂuorescence intensity relative to control cells. Unstained cellsdisplayed weak ﬂuorescence with partial overlap with the ﬂuo-
rescence of Nile red stained cells. By subtraction analysis,
around 23–25% cells treated with nanoemulsions were found
to have greater ﬂuorescence intensity than control cells, thus
conﬁrming the internalization of the nanoemulsions (Fig. 4).
4. Conclusion
Colloidally stable cationic nanoemulsions were successfully
fabricated using DDAB to render positive charge on surface
of globules. The properties of the cationic nanoemulsions were
inﬂuenced by selection and concentration of an oil, non ionic
and the cationic surfactant. Inclusion of phospholipids enabled
cationic nanoemulsions to maintain sufﬁcient colloidal stabil-
ity even after steam sterilization. The cationic nanoemulsions
showed improved DNA condensation even at lower DNA:
carrier ratio of 1:1. Future studies which evaluate higher car-
rier: DNA ratios and transfection efﬁciency will be useful. In
vivo study can give further insight and validation of effective
gene delivery.
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